Journal article
Hyperprolactinemia and Contraception: A Prospective Study
Obstetrics and gynecology (New York. 1953), Vol.65(4), pp.506-510
04/1985
PMID: 3982724
Abstract
The authors measured serum concentrations by single and multiple sampling techniques in 347 women before, during, and after treatment with either hormonal or barrier methods of contraception. The prolactin responses to an intramuscular injection of estrogen also were evaluated in control and selected study patients. The incidence of hyperprolactinemia in oral contraceptive users was higher than control subjects (12 versus 5%). Hyperprolactinemia was best assessed by multiple blood sampling, it is often transient and resolves spontaneously in about 50% of women. The estrogen provocation study suggests that some women who develop hyperprolactinemia while taking oral contraceptives are more sensitive to the effects of exogenous estrogen and may be at greater risk of developing pill-related menstrual aberrations and hyperprolactinemia.
Details
- Title: Subtitle
- Hyperprolactinemia and Contraception: A Prospective Study
- Creators
- ANTHONY Luciano - University of IowaBARRY ShermanFREDERICK ChaplerKATHERINE HauserROBERT Wallace
- Resource Type
- Journal article
- Publication Details
- Obstetrics and gynecology (New York. 1953), Vol.65(4), pp.506-510
- PMID
- 3982724
- NLM abbreviation
- Obstet Gynecol
- ISSN
- 0029-7844
- eISSN
- 1873-233X
- Publisher
- The American College of Obstetricians and Gynecologists
- Language
- English
- Date published
- 04/1985
- Academic Unit
- Epidemiology; Obstetrics and Gynecology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984364402402771
Metrics
11 Record Views